Addressing the issue of cost of treatment in CLL
Overview of the International Conference on Malignant Lymphoma (ICML) 2017
Isatuximab and pomalidomide for the treatment of MM
Joseph R. Mikhael
What does the CLL forum data tell us?
Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL